HEIDELBERG PHARMA AG O.N. (HPHA) — research page
DE · de-cm-kg/XETRA/HPHA · as of 2026-11-06
Identity and listing
The issuer is HEIDELBERG PHARMA AG O.N., listed on Xetra under ticker HPHA, with ISIN DE000A11QVV0 and LEI 391200E09XYBYITR1W32. Its security type is Corporate, its segment is DEUTSCHLAND, and its jurisdiction is Germany (Handelsregister HRB). The sector is not on the record. The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | HEIDELBERG PHARMA AG O.N. | source · 2026-11-06 |
| exchange | Xetra | source · 2026-11-06 |
| ticker | HPHA | source · 2026-11-06 |
| ISIN | DE000A11QVV0 | source · 2026-11-06 |
| LEI | 391200E09XYBYITR1W32 | source · 2026-11-09 |
| security type | Corporate | source · 2026-11-06 |
| segment | DEUTSCHLAND | source · 2026-11-06 |
| sector | not on the record | |
| jurisdiction | Germany (Handelsregister HRB) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 11 filings in the twelve months to 2026-11-06, across 8 filing days. Of these, 10 are corporate_news and 1 is newswire_release. The median gap between filing days is 20 days. The latest filing is dated 2026-11-04, 2 days before the record date, and is of type corporate_news. The exchange median for Xetra is 6 filings, a cadence gap of 22.8 days, and a latency of 5.5 days, across 419 issuers. The sector median is not on the record.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 11 | 20 | 2 |
| exchange median: Xetra (419 issuers) | 6 | 22.8 | 5.5 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-04 | corporate_news | corporate | Heidelberg Pharma to Present New Clinical Data on its ATAC Candidates at the ASH Annual Meeting 2026 | Corporate - EQS News |
| 2026-11-04 | corporate_news | corporate-news | Heidelberg Pharma präsentiert neue klinische Daten ihrer ATAC-Kandidaten auf der Jahrestagung 2026 der American Society of Hematology (ASH) | Corporate - EQS News |
| 2026-10-15 | corporate_news | corporate-news | Heidelberg Pharma berichtet über die ersten neun Monate des Geschäftsjahres 2026 | Corporate - EQS News |
| 2026-10-14 | corporate_news | corporate | Heidelberg Pharma Reports on the First Nine Months of Financial Year 2026 | Corporate - EQS News |
| 2026-09-07 | corporate_news | corporate | Heidelberg Pharma to Present New Clinical Data on Lead ATAC Candidate Pamlectabart Tismanitin at International Myeloma Society Annual Meeting 2026 | Corporate - EQS News |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is not on the record. The record carries only the annual report link, which is a source link and not a read. The auditor's location is not on the record, and auditor changes are not on the record.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, because this register has no lifecycle type map yet. The issuer is not halted.
Orderability
The signal ACM-200 is determinable for all three client categories: Professionelle Kunden, Privatkunden and Geeignete Gegenparteien. The rule version is acm-68000/de/mifid-ii-product-governance-produkt-berwachung/r1, and the chapter is as of 2026-11-04.
| client category | outcome |
|---|---|
| Geeignete Gegenparteien | ACM-200 |
| Privatkunden | ACM-200 |
| Professionelle Kunden | ACM-200 |
rule acm-68000/de/mifid-ii-product-governance-produkt-berwachung/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's own investor-relations page names 3 research houses: Pareto Secruties AS, Pareto Securities AG, and Pareto Secruties AS Equity Research.
| research house | analyst | source · read date |
|---|---|---|
| Pareto Secruties AS | Dr Marcus Wieprecht | issuer page · 2026-11-12 |
| Pareto Securities AG | issuer page · 2026-11-12 | |
| Pareto Secruties AS Equity Research | Dr Marcus Wieprecht | issuer page · 2026-11-12 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed, and the market's earliest sealed date and the live record start date are not on the record.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.xetra.com/xetra-en/instruments/shares/list-of-tradable-shares (identity.exchange)
- 10.2
- https://api.gleif.org/api/v1/lei-records/391200E09XYBYITR1W32 (identity.jurisdiction)
- 10.3
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.4
- https://mcp.de-cm-kg.ai/events/XETRA/HPHA (the disclosure lines)
- 10.5
- https://www.cashmarket.deutsche-boerse.com/cash-en/Stay-Informed/current-regulatory-topics/mifid-ii-releases/4086638!suspension-list (the halt flag)
- 10.6
- https://mcp.de-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.7
- https://heidelberg-pharma.com/en/press-investors/shareholderinformation/analysts (coverage)
- 10.8
- https://mcp.de-cm-kg.ai/record/XETRA/HPHA (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"DE000A11QVV0"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:538593b5c257dc11.